FDA — authorised 18 May 1976
- Marketing authorisation holder: PHARMACIA AND UPJOHN
- Status: approved
FDA authorised Enzaprost on 18 May 1976
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 18 May 1976.
PHARMACIA AND UPJOHN holds the US marketing authorisation.